Abstract
Protamines are the predominant nuclear proteins in testicular spermatids and ejaculated spermatozoa. During spermiogenesis, protamine–DNA interaction induces a higher-order chromatin packaging which finally results in a complete transcriptional stop in elongating spermatids. Although numerous studies investigated the role of protamines in male fertility, to date, no study is available that investigates protamine function, particularly transcriptional silencing, in non-germ cells. Transcriptional stop due to the high binding affinity of arginine-rich protamines to the negatively charged DNA backbone, however, may be induced in somatic cells and may result in suppressing cell division in tumor cells. In the present study, we therefore analyzed whether a protamine-mediated chromatin condensation in somatic cancer cell lines can stop gene expression and arrest cancer cell proliferation. In contrast to terminally differentiated sperm, cancer cells represent immortalized cells that have modulated natural mechanisms for the regulation of apoptosis and cell proliferation. We expressed human protamines in two fast-growing cell systems, E. coli and HeLa cells. In both cases, protamine expression significantly attenuated cell proliferation when compared with control cells. To our knowledge, this is the first study that demonstrates a stop of cell proliferation in both E. coli and HeLa cells by protamine expression. Follow-up studies on the molecular effect of protamines on proliferative cells may, in the future, open new avenues to investigate effective and specific treatments of cancer cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aoki VW, Liu L, Jones KP, Hatasaka HH, Gibson M, Peterson CM, Carrell DT (2006) Sperm protamine 1/protamine 2 ratios are related to in vitro fertilization pregnancy rates and predictive of fertilization ability. Fertil Steril 86(5):1408–1415. doi:10.1016/j.fertnstert.2006.04.024
Balhorn R, Reed S, Tanphaichitr N (1988) Aberrant protamine 1/protamine 2 ratios in sperm of infertile human males. Experientia 44(1):52–55
Biermann K, Steger K (2007) Epigenetics in male germ cells. J Androl 28(4):466–480. doi:10.2164/jandrol.106.002048
Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI (2007) The multifunctional nucleolus. Nat Rev Mol Cell Biol 8(7):574–585. doi:10.1038/nrm2184
Braun RE (2001) Packaging paternal chromosomes with protamine. Nat Genet 28(1):10–12. doi:10.1038/88194
Cao Y, DePinho RA, Ernst M, Vousden K (2011) Cancer research: past, present and future. Nat Rev Cancer 11(10):749–754. doi:10.1038/nrc3138
Castillo J, Amaral A, Oliva R (2014) Sperm nuclear proteome and its epigenetic potential. Andrology 2(3):326–338. doi:10.1111/j.2047-2927.2013.00170.x
Cho C, Willis WD, Goulding EH, Jung-Ha H, Choi YC, Hecht NB, Eddy EM (2001) Haploinsufficiency of protamine-1 or -2 causes infertility in mice. Nat Genet 28(1):82–86. doi:10.1038/88313
Crameri A, Whitehorn EA, Tate E, Stemmer WP (1996) Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat Biotechnol 14(3):315–319. doi:10.1038/nbt0396-315
Drygin D, Rice WG, Grummt I (2010) The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu Rev Pharmacol Toxicol 50:131–156. doi:10.1146/annurev.pharmtox.010909.105844
Fedorova E, Zink D (2008) Nuclear architecture and gene regulation. Biochim Biophys Acta 1783(11):2174–2184. doi:10.1016/j.bbamcr.2008.07.018
Grunewald S, Paasch U, Glander H-J, Anderegg U (2005) Mature human spermatozoa do not transcribe novel RNA. Andrologia 37:69–71. doi:10.1111/j.1439-0272.2005.00656.x
Gunther K, Rust M, Leers J, Boettger T, Scharfe M, Jarek M, Bartkuhn M, Renkawitz R (2013) Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences. Nucleic Acids Res 41(5):3010–3021. doi:10.1093/nar/gkt035
Hahn WC, Weinberg RA (2002a) Modelling the molecular circuitry of cancer. Nat Rev Cancer 2(5):331–341. doi:10.1038/nrc795
Hahn WC, Weinberg RA (2002b) Rules for making human tumor cells. N Engl J Med 347(20):1593–1603. doi:10.1056/NEJMra021902
Hud NV, Allen MJ, Downing KH, Lee J, Balhorn R (1993) Identification of the elemental packing unit of DNA in mammalian sperm cells by atomic force microscopy. Biochem Biophys Res Commun 193(3):1347–1354. doi:10.1006/bbrc.1993.1773
Kanippayoor RL, Alpern JH, Moehring AJ (2013) Protamines and spermatogenesis in and: a comparative analysis. Spermatogenesis 3(2):e24376. doi:10.4161/spmg.24376
Lanctot C, Cheutin T, Cremer M, Cavalli G, Cremer T (2007) Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat Rev Genet 8(2):104–115. doi:10.1038/nrg2041
Luo J, Solimini NL, Elledge SJ (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136(5):823–837. doi:10.1016/j.cell.2009.02.024
Martins RP, Krawetz SA (2007) Nuclear organization of the protamine locus. Soc Reprod Fertil suppl 64:1–12
Millar MR, Sharpe RM, Weinbauer GF, Fraser HM, Saunders PT (2000) Marmoset spermatogenesis: organizational similarities to the human. Int J Androl 23(5):266–277
Misteli T (2005) Concepts in nuclear architecture. BioEssays 27(5):477–487. doi:10.1002/bies.20226
Nemeth A, Langst G (2011) Genome organization in and around the nucleolus. Trends Genet 27(4):149–156. doi:10.1016/j.tig.2011.01.002
Oliva R, Castillo J (2011) Proteomics and the genetics of sperm chromatin condensation. Asian J Androl 13(1):24–30. doi:10.1038/aja.2010.65
Oliva R, Dixon GH (1990) Vertebrate protamine gene evolution I. Sequence alignments and gene structure. J Mol Evol 30(4):333–346
Reeves RH, Gearhart JD, Hecht NB, Yelick P, Johnson P, O’Brien SJ (1989) Mapping of PRM1 to human chromosome 16 and tight linkage of Prm-1 and Prm-2 on mouse chromosome 16. J Hered 80(6):442–446
Rogenhofer N, Dansranjavin T, Schorsch M, Spiess A, Wang H, von Schonfeldt V, Cappallo-Obermann H, Baukloh V, Yang H, Paradowska A, Chen B, Thaler CJ, Weidner W, Schuppe HC, Steger K (2013) The sperm protamine mRNA ratio as a clinical parameter to estimate the fertilizing potential of men taking part in an ART programme. Hum Reprod 28(4):969–978. doi:10.1093/humrep/des471
Sakahira H, Enari M, Nagata S (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391(6662):96–99. doi:10.1038/34214
Schagdarsurengin U, Paradowska A, Steger K (2012) Analysing the sperm epigenome: roles in early embryogenesis and assisted reproduction. Nat Rev Urol 9:609–619. doi:10.1038/nrurol.2012.183
Scheel B, Teufel R, Probst J, Carralot JP, Geginat J, Radsak M, Jarrossay D, Wagner H, Jung G, Rammensee HG, Hoerr I, Pascolo S (2005) Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA. Eur J Immunol 35(5):1557–1566. doi:10.1002/eji.200425656
Sorgi FL, Bhattacharya S, Huang L (1997) Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther 4(9):961–968. doi:10.1038/sj.gt.3300484
Tamm I, Kikuchi T (1983) Inhibition of HeLa-S3 cell proliferation and biosynthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB). Proc Soc Exp Biol Med Soc Exp Biol Med 173(2):238–243
Taylor RC, Cullen SP, Martin SJ (2008) Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9(3):231–241. doi:10.1038/nrm2312
Wang YH, Davies AH, Jones IM (1995) Expression and purification of glutathione S-transferase-tagged HIV-1 gp120: no evidence of an interaction with CD26. Virology 208(1):142–146. doi:10.1006/viro.1995.1137
Ward WS, Coffey DS (1991) DNA packaging and organization in mammalian spermatozoa: comparison with somatic cells. Biol Reprod 44(4):569–574
Wykes SM, Krawetz SA (2003) The structural organization of sperm chromatin. J Biol Chem 278(32):29471–29477. doi:10.1074/jbc.M304545200
Yao YD, Sun TM, Huang SY, Dou S, Lin L, Chen JN, Ruan JB, Mao CQ, Yu FY, Zeng MS, Zang JY, Liu Q, Su FX, Zhang P, Lieberman J, Wang J, Song E (2012) Targeted delivery of PLK1-siRNA by ScFv suppresses Her2 + breast cancer growth and metastasis. Sci Transl Med 4(130):130ra148. doi:10.1126/scitranslmed.3003601
Acknowledgments
This work was supported by the German Research Foundation (DFG) within Clinical Research Unit (KFO) 181 (KG, APD, WW, KS). We would like to acknowledge colleagues from the Institute for Genetics, Justus Liebig University of Giessen, for providing us with HeLa Cells. We also thank Barbara Fröhlich for technical assistance and Mareike Buch-Heberling for editing of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Katharina Günther and Agnieszka Paradowska-Dogan have contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Günther, K., Paradowska-Dogan, A., Bärmann, B. et al. Expression of sperm-specific protamines impairs bacterial and eukaryotic cell proliferation. Histochem Cell Biol 143, 599–609 (2015). https://doi.org/10.1007/s00418-015-1309-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-015-1309-3